Proteome Sciences plc (LON:PRM – Get Free Report) traded up 10.7% on Monday . The company traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.40 ($0.04). 966,870 shares were traded during mid-day trading, an increase of 496% from the average session volume of 162,145 shares. The stock had previously closed at GBX 3.07 ($0.04).
Proteome Sciences Stock Up 9.0 %
The stock has a market capitalization of £9.89 million, a P/E ratio of -335.00 and a beta of 0.07. The business has a fifty day moving average price of GBX 2.71 and a 200-day moving average price of GBX 3.16.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Articles
- Five stocks we like better than Proteome Sciences
- What is the Dow Jones Industrial Average (DJIA)?
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Time to Board Carnival Cruise Lines’ Stock Price Rally
- What is Put Option Volume?
- Is Warner Bros. Discovery Stock a Buy After Recent Drop?
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
